Neutrahealth Share Discussion Threads

[geovest] 07/3/2008 17:34

Two different markets (exchanges). There may be small differences sometimes but not for example enough to allow someone to buy on Plus and see on AIM for a profit.

[longshanks] 07/3/2008 16:53

Can anyone explain the reason why the prices and trend shown for PLUS:NUT.GB differ to those for LSE:NUT?

[s_e] 06/3/2008 10:11

From The TimesMarch 6, 2008

In the know

Tiddler to watch

Neutrahealth has not had a sickly price performance since its 2005 flotation, but the shares rose 1.125p to 9p yesterday after strong results. It has increased the number of chemists stocking its vitamins from 1,000 to 20,000 in the past year and predicts 75 per cent sales growth for CoQ10, an enzyme that the body uses to produce energy.

I bought in..

Date Broker name New Price Old price target New price target Broker change
26-Jul-07 Daniel Stewart Buy 13.25p 17.00p - Reiteration
31-May-07 Daniel Stewart Buy 13.00p - 17.00p Reiteration
21-May-07 Daniel Stewart Buy 10.75p 13.00p - Reiteration
27-Apr-07 Daniel Stewart Buy 9.75p 12.80p - Reiteration
06-Mar-07 Daniel Stewart Buy 10.38p - 12.80p New Coverage

[geovest] 06/3/2008 09:34

Agreed. Capital is a scarce resource and it is one of the most important responsibilities of Managers to take the difficult decisions to allocate capital profitably. Only those that do this successfully, whilst containing cost, go on to create great businesses.

[longshanks] 06/3/2008 09:12

They do say that they can now make acquisitions from debt thanks in large part to the Elder investment....just feel that the company is a bit frustrated that it can't go after the bigger fish without adversely diluting share value.

This share is not alone in having trouble establishing "fair" value for its equity. A forward P/E of less 8 for a business in a market segment seeing 15% annual growth seems totally barmy though. Plenty of ops for PI's though ;)

When sentiment to small caps does change (and it will), it is the strong stocks like this that will benefit.

In reference to the results the thing that impressed me most is the way that they are evaluating things so comprehensively as to where cash is invested in the business. They mention, in relation to Travelguard:
Our analysis concluded that the marketing resource necessary would generate a better return applied elsewhere across the Group.

I hate the bean counters that restrict my own work activities but tight control of resources like this is what makes the difference between the good and the best run businesses.

[felix99] 06/3/2008 08:53

true they can;t below nominal value but then the whole idea fo the indian outfit buying in was to give them cash so they didn;t have to issue shares at like 10 or 11p whihc they thought was too cheap at the time - never mind here.

Also lots of inst holdings and suspect a few are having to sell out in current climate due to risk boys upstairs ameding criteria of what they can hold

[longshanks] 05/3/2008 15:35

Can't agree with you more.

Only ink here seems to be someone who is offloading bundles of these - presumably what has driven the price down in recent months. Seems strange to me that this share should be trading below its nominal value....does this have any impact on the company's ability to raise equity - surely they can't issue any shares at a price less than 10p?

[geovest] 05/3/2008 09:37

Longshanks, I think 1.2p is probably probably reasonable given the current trading, (ie strong growth from Brunel, fairly flat Biocare plus recent small acquisitions), given that there will still be some EPS dilution in the first half because of Elder.

Further acquisitions this year (which seems imminent) should be earnings enhancing, leading to broker forecast earnings upgrades later this year, but we will have to wait and see what they buy.

At 9.75 and a forecast EPS of 1.2p it is still trading on a forward PE of 8.1, which is very cheap considering that its a fairly low risk business.

In addition, Elder's option to subscribe for additional shares to keep their stake at 20% expires in November 2008. Elder is looking for a foothold in the UK. They recently said that they are not looking for new acquisition but will consider consolidating/expanding their existing overseas investments, which consists of NUT and a small factory in Europe. We may just see an all-out bid from Elder this year.

Low risk, great potential upside with or without a bid.

[pro_better] 05/3/2008 09:02

there we go....as expected....:)

[longshanks] 05/3/2008 08:17

Current forecast EPS is 1.2p for 2008 - do you think this is conservative given the scope for acquisitions and how well the current ones have been integrated, Geovest?

[geovest] 05/3/2008 08:12

Good results and good prospects with strong acquisition pipeline. I've been loading up in late Jan and early Feb when it hits all time lows. Looking forward to some good returns over the next few years.

[longshanks] 05/3/2008 08:04

Cracking set of results. Can't believe these have got so cheap.

[fludde] 11/12/2007 13:16

Looks like I got the timing wrong on this one. Hope 2008 brings some progress.

[pro_better] 20/10/2007 12:55

Develops and manufactures health food supplements.

The company trades on forward price/earnings ratio of 29, yet earnings are expected to rise over the next months

[cyclingnut] 18/10/2007 11:30

just been alerted to this stock....looks like a good med/long term investment

[fludde] 16/10/2007 14:43

Good news- a reduction of short term liability. Also a positive incentive going forward so do not see any reason for the share price drop.

[fludde] 01/10/2007 15:51

Another Director buy- good omen.

[fludde] 21/9/2007 15:27

Picked up a few earlier this week on a tip. Nice start...

[cambium] 21/9/2007 14:41

cheap as chips

[diogenesj] 21/9/2007 13:42

CEO buys 100k shares today at 11.75p.

[felix99] 26/7/2007 13:47

Good luck 1Smart - cheap it isn't anymore . It had good potential at 9.7p mind you. I do think without this 16p issue lark the price would at least be back here if not more.

Fact is I think the forecasts were for 1p EPS this year. They done 0.4p first half and so have to go some to make their forecast. Factor in 20% dilution to EPS and that means its trading on a fairly hefty p/e for where it is now. Plenty of jam tomorrow factored in especially by Elder - barking imho at 16p but hey its their money

[james t kirk] 26/7/2007 08:27

Online limits:

Buy 250k @ 14.5p
Sell 50k @ 14p

[1smart] 26/7/2007 08:22

give it time im in and backers take [e-mail] places with plenty in the pipeline.my buy not showing yet